Mohammad Sheibani

1.1k total citations · 1 hit paper
58 papers, 704 citations indexed

About

Mohammad Sheibani is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mohammad Sheibani has authored 58 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mohammad Sheibani's work include Circadian rhythm and melatonin (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers) and Metabolism, Diabetes, and Cancer (3 papers). Mohammad Sheibani is often cited by papers focused on Circadian rhythm and melatonin (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (7 papers) and Metabolism, Diabetes, and Cancer (3 papers). Mohammad Sheibani collaborates with scholars based in Iran, United States and Armenia. Mohammad Sheibani's co-authors include Ahmad Reza Dehpour, Sadaf Nezamoleslami, Maryam Shayan, Yaser Azizi, Faezeh Eslami, Mohammad Hadi Farjoo, Hedyeh Faghir‐Ghanesefat, Hasan Yousefi‐Manesh, Mehdi Ghasemi and Saeed Mehrzadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Ethnopharmacology and Life Sciences.

In The Last Decade

Mohammad Sheibani

56 papers receiving 689 citations

Hit Papers

Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-cl... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches
    2022 152 citations Mohammad Sheibani, Yaser Azizi et al. Cardiovascular Toxicology profile →

Peers

Mohammad Sheibani
Jieyu Chen China
Perle Totoson France
Sheng-Feng Lu China
Qing-Bo Lu China
Yaser Azizi Iran
Shi-Yi Zhou China
María Dolores Mauricio Spain
Mingjing Yan China
Patricia Marchio Spain
Yanfei Wang China
Jieyu Chen China
Mohammad Sheibani
Citations per year, relative to Mohammad Sheibani Mohammad Sheibani (= 1×) peers Jieyu Chen

Countries citing papers authored by Mohammad Sheibani

Since Specialization
Citations

This map shows the geographic impact of Mohammad Sheibani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Sheibani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Sheibani more than expected).

Fields of papers citing papers by Mohammad Sheibani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Sheibani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Sheibani. The network helps show where Mohammad Sheibani may publish in the future.

Co-authorship network of co-authors of Mohammad Sheibani

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Sheibani. A scholar is included among the top collaborators of Mohammad Sheibani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Sheibani. Mohammad Sheibani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Avagimyan, Ashot, et al.. (2025). Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 2). SHILAP Revista de lepidopterología. 10(1). 101–109. 2 indexed citations
2.
Sheibani, Mohammad, et al.. (2025). Protective effects of apigenin in neurodegeneration: An update on the potential mechanisms. SHILAP Revista de lepidopterología. 17. 100189–100189. 4 indexed citations
3.
Sheibani, Mohammad, et al.. (2025). Metalloproteinases (MMPs) in hypertensive disorders: role, function, pharmacology, and potential strategies to mitigate pathophysiological changes. Frontiers in Pharmacology. 16. 1559288–1559288. 1 indexed citations
4.
Kiaie, Seyed Hossein, et al.. (2024). Novel synthesized ionizable lipid for LNP-mediated P2X7siRNA to inhibit migration and induce apoptosis of breast cancer cells. Purinergic Signalling. 20(5). 533–546. 5 indexed citations
5.
6.
Avagimyan, Ashot, et al.. (2024). Protective Potential of Sodium-Glucose Cotransporter 2 Inhibitors in Internal Medicine (Part 1). SHILAP Revista de lepidopterología. 126–135. 3 indexed citations
7.
Motevalian, Manijeh, et al.. (2024). Zhumeria majdae essential oil attenuates TNBS-induced colitis in rats by regulating inflammatory and apoptotic pathways. Inflammopharmacology. 32(6). 3809–3824. 3 indexed citations
8.
Jafari, Razieh Mohammad, Mohammad Sheibani, Amir Rashidian, et al.. (2024). Sumatriptan mitigates bleomycin-induced lung fibrosis in male rats: Involvement of inflammation, oxidative stress and α-SMA. Tissue and Cell. 88. 102349–102349. 6 indexed citations
9.
Hosseinzadeh, Azam, et al.. (2024). Melatonin: Current evidence on protective and therapeutic roles in gynecological diseases. Life Sciences. 344. 122557–122557. 5 indexed citations
10.
Avagimyan, Ashot, et al.. (2024). The place of beta-adrenergic receptor blockers in the treatment of arterial hypertension: From bench-to-bedside. Current Problems in Cardiology. 49(10). 102734–102734. 3 indexed citations
11.
12.
Avagimyan, Ashot, et al.. (2023). Comparison of Cardioprotective Effects of Dapagliflozin and Trimetazidine in the Model of Doxorubicin-Cyclophosphamide Cardiotoxicity. SHILAP Revista de lepidopterología. 6–14. 2 indexed citations
13.
Hosseinzadeh, Azam, Mohammad Hossein Pourhanifeh, Mohammad Sheibani, et al.. (2023). Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis. Pharmacological Reports. 76(1). 25–50. 13 indexed citations
14.
Sheibani, Mohammad, Yaser Azizi, Maryam Shayan, et al.. (2022). Doxorubicin-Induced Cardiotoxicity: An Overview on Pre-clinical Therapeutic Approaches. Cardiovascular Toxicology. 22(4). 292–310. 152 indexed citations breakdown →
15.
Yousefi‐Manesh, Hasan, Ahmad Reza Dehpour, Seyed Mohammad Nabavi, et al.. (2021). Therapeutic Effects of Hydroalcoholic Extracts from the Ancient Apple Mela Rosa dei Monti Sibillini in Transient Global Ischemia in Rats. Pharmaceuticals. 14(11). 1106–1106. 15 indexed citations
16.
Sheibani, Mohammad, et al.. (2021). Glatiramer acetate treatment inhibits inflammatory responses and improves survival in a mice model of cecal ligation and puncture-induced sepsis. Journal of Basic and Clinical Physiology and Pharmacology. 33(3). 317–326. 1 indexed citations
17.
Yousefi‐Manesh, Hasan, et al.. (2021). Protective effect of dapsone against bleomycin-induced lung fibrosis in rat. Experimental and Molecular Pathology. 124. 104737–104737. 19 indexed citations
18.
Avagimyan, Ashot, et al.. (2021). AC-Mode of Chemotherapy as a Trigger of Cardiac Syndrome X: A Case Study. Current Problems in Cardiology. 47(9). 100994–100994. 14 indexed citations
19.
Sheibani, Mohammad, et al.. (2020). The protective effects of curcumin and curmumin nanomicelle against cirrhotic cardiomyopathy in bile duct-ligated rats. SHILAP Revista de lepidopterología. 7(2). 158–169. 2 indexed citations
20.
Jafari, Razieh Mohammad, et al.. (2018). Drug Repositioning: A Review. 1(1). 7–10. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jieyu Chen Breakdown of academic impact, for papers by Perle Totoson Breakdown of academic impact, for papers by Sheng-Feng Lu Breakdown of academic impact, for papers by Qing-Bo Lu Breakdown of academic impact, for papers by Yaser Azizi Breakdown of academic impact, for papers by Shi-Yi Zhou Breakdown of academic impact, for papers by María Dolores Mauricio Breakdown of academic impact, for papers by Mingjing Yan Breakdown of academic impact, for papers by Patricia Marchio Breakdown of academic impact, for papers by Yanfei Wang
Rankless by CCL
2026